Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MIP Technologies Presents New Range of RENSA™ Industrial Resins

Published: Monday, January 27, 2014
Last Updated: Monday, January 27, 2014
Bookmark and Share
New range of polymeric separation resins for industrial use.

MIP Technologies has presented a new range of RENSA™ industrial resins. The company is now offering industrial resin products together with recently published product- and application notes on the website http://www.biotage.com/product-page/rensa-bulk-resins.

These notes describe the materials and physical properties as well as the performance of the new resins so that customers can select the appropriate resin for their specific separation requirements.

“The food, beverage, pharma, consumer products and life science industries are constantly confronted with new separation challenges as the result of an ever changing regulatory environment and the pressure to achieve a better process economy. In response to this need, MIP Technologies has established a broad range of polymeric materials spanning a wide chemistry landscape that will enable these industries to overcome those separation challenges” says Dr. Ecevit Yilmaz, Product Manager – Industrial Resins.

Dr. Yilmaz continued, “The separation materials can be used by our customers at the pilot and production scale to either extract undesired impurities or to enrich specific target compounds from complex matrices.”

“The area of Industrial Scale applications is an important new pillar in the business of Biotage. We will continue to invest into the development of our Industrial Resin portfolio and we will further expand the range of engineered polymeric adsorbents. This will allow us to offer unique and highly selective separation solutions to our wide range of industrial customers” says Dr. Ecevit Yilmaz.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Cancer Discovery Links Experimental Vaccine and Biological Treatment
A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!